Rojanasarot Sirikan, Heins Nesvold Jill, Karaca-Mandic Pinar, St Peter Wendy L, Wolfson Julian, Schommer Jon C, Carlson Angeline M
a Department of Pharmaceutical Care & Health Systems, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota , USA.
b American Lung Association , St. Paul , Minnesota , USA.
J Asthma. 2019 Apr;56(4):440-450. doi: 10.1080/02770903.2018.1463378. Epub 2018 May 11.
This study investigated the effectiveness of Enhancing Care for Patients with Asthma (ECPA)-a collaborative quality improvement program implemented in 65 community health centers that serve asthma patients in four states-on clinic-based asthma performance measures consistent with national guidelines.
This study utilized a pretest-posttest quasi-experimental design. Six clinic-based performance measures of each center were collected from a retrospective chart review at time points: before the ECPA implementation; at the end of the 12-month long ECPA program; and 6 months after program completion. The effectiveness of the ECPA was assessed using generalized linear mixed models with a Poisson distribution and log link by evaluating the change in each measure from baseline to program completion, from baseline to 6-month post-program completion and from program completion to 6-month post-program completion.
The ECPA implementation was positively associated with improvement in all measures from baseline to program completion: documentation of asthma severity (rate ratio (RR) 1.314; 95% confidence interval (CI) 1.206, 1.432); Asthma Control Test (RR 3.625; 95% CI 3.185, 4.124); pulmonary function testing (RR 1.771; 95% CI 1.527, 2.054), asthma education (RR 2.246; 95% CI 2.018, 2.501), asthma action plan (RR 2.335; 95% CI 2.070, 2.634) and controller medication (RR 1.961; 95% CI 1.504,2.556). Improvement was sustained for all six measures at the 6-month post-program completion time point.
This study demonstrated the favorable effect of the ECPA program on evidence-based asthma quality measures. This program could be considered a model worth replication on a broader scale.
本研究调查了“加强哮喘患者护理”(ECPA)——一项在四个州为哮喘患者服务的65家社区卫生中心实施的合作质量改进项目——对符合国家指南的基于诊所的哮喘绩效指标的有效性。
本研究采用前后测准实验设计。在以下时间点通过回顾性病历审查收集每个中心的六项基于诊所的绩效指标:ECPA实施前;为期12个月的ECPA项目结束时;项目完成后6个月。通过使用具有泊松分布和对数链接的广义线性混合模型,评估从基线到项目完成、从基线到项目完成后6个月以及从项目完成到项目完成后6个月各项指标的变化,来评估ECPA的有效性。
从基线到项目完成,ECPA的实施与所有指标的改善呈正相关:哮喘严重程度记录(率比(RR)1.314;95%置信区间(CI)1.206,1.432);哮喘控制测试(RR 3.625;95% CI 3.185,4.124);肺功能测试(RR 1.771;95% CI 1.527,2.054),哮喘教育(RR 2.246;95% CI 2.018,2.501),哮喘行动计划(RR 2.335;95% CI 2.070,2.634)和控制药物(RR 1.961;95% CI 1.504,2.556)。在项目完成后6个月的时间点,所有六项指标的改善都得以持续。
本研究证明了ECPA项目对基于证据的哮喘质量指标的积极影响。该项目可被视为一个值得在更广泛范围内推广的模式。